Creativity sparks a bright future for science

When some people want to see the future they use a crystal ball. Others use tarot cards or runes. But when anyone at CIRM wants to see the future all we have to do is look into the faces of the students in our Creativity program. Over the past three years the Creativity program has … Continue reading Creativity sparks a bright future for science

Bridging the gap: training scientists to speak everyday English

Getting a start in your chosen career is never easy. Without experience it’s hard to get a job. And without a job you can’t get experience. That’s why the CIRM Bridges program was created, to help give undergraduate and Master’s level students a chance to get the experience they need to start a career in … Continue reading Bridging the gap: training scientists to speak everyday English

Improving process drives progress in stem cell research

Process is not a sexy word. No one gets excited thinking about improving a process. Yet behind every great idea, behind every truly effective program is someone who figured out a way to improve the process, to make that idea not just work, but work better. It’s not glamorous. Sometimes it’s not even pretty. But … Continue reading Improving process drives progress in stem cell research

Two for 2.0 and Two for us

It began as an ambitious idea; yesterday it became a reality when the CIRM Board approved two projects under CIRM 2.0, one of them a Phase 3 clinical trial for a deadly form of skin cancer. Just to recap, CIRM 2.0 was introduced by Dr. C. Randal Mills when he took over as President and … Continue reading Two for 2.0 and Two for us

How venture capital became a capital adventure for stem cell agency’s newest Board member

There’s something fascinating about looking at the arc of a person’s career. So often we start out thinking we are going to be one thing, and over the years we move in a different direction and end up doing something else entirely. That’s certainly the case with Kathy LaPorte, the newest addition to our governing … Continue reading How venture capital became a capital adventure for stem cell agency’s newest Board member